Corresponding Author: Steven Joffe, MD, MPH, Department of Medical Ethics and Health Policy, University of Pennsylvania Perelman School of Medicine, 423 Guardian Dr, BH1413, Philadelphia, PA 19104 (joffes@upenn.edu).
Published Online: December 14, 2020. doi:10.1001/jama.2020.25127
Conflict of Interest Disclosures: Dr Joffe is a member of the independent data and safety monitoring board responsible for oversight of SARS-CoV-2 clinical trials supported by Operation Warp Speed, for which he receives an honorarium of $200 per meeting from the National Institute of Allergy and Infectious Diseases. He received research funding from Pfizer through the University of Pennsylvania until May 2020.
Disclaimer: The views expressed here are the author’s own and do not necessarily reflect those of the DSMB or of any of the entities with which it is affiliated.
2.Zimmer
C , Weiland
N . Should volunteers who got placebo be first to get the real thing? New York Times. December 3, 2020:A7.
4.WHO Ad Hoc Expert Group on the Next Steps for Covid-19 Vaccine Evaluation. Placebo-controlled trials of Covid-19 vaccines—why we still need them.
N Engl J Med. Published online December 2, 2020. doi:
10.1056/NEJMp2033538Google Scholar 5.Goodnough
A. Everything you wanted to know about the shot. New York Times. December 3, 2020:A7.
6.Center for Biologics Evaluation and Research. Development and licensure of vaccines to prevent COVID-19: guidance for industry. US Food and Drug Administration. Published June 2020. Accessed December 2, 2020.
https://www.fda.gov/media/139638/download 10.Angus
DC , Derde
L , Al-Beidh
F ,
et al; Writing Committee for the REMAP-CAP Investigators. Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 Corticosteroid Domain randomized clinical trial.
JAMA. 2020;324(13):1317-1329. doi:
10.1001/jama.2020.17022PubMedGoogle ScholarCrossref